产品封面图
文献支持

CAL33细胞

收藏
  • ¥1980
  • EK-Bioscience已认证
  • CCC-Y1826
  • 2025年07月12日
    avatar
    品牌商
    12钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    CAL33/CAL33细胞系/CAL33细胞株/CAL33舌鳞状细胞癌

    Cell line name CAL-33

    Synonyms Cal-33; CAL 33; CAL33; CAL-SCC-33; Centre Antoine Lacassagne-33

    Accession CVCL_1108

    Resource Identification Initiative To cite this cell line use: CAL-33 (RRID:CVCL_1108)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Part of: OPC-22 oral and pharyngeal cancer cell line panel.

    Population: Caucasian.

    Doubling time: 78 hours (PubMed=2145926); ~30-40 hours (DSMZ=ACC-447).

    Microsatellite instability: Stable (MSS) (Sanger).

    Omics: CRISPR phenotypic screen.

    Omics: Deep exome analysis.

    Omics: Deep quantitative proteome analysis.

    Omics: DNA methylation analysis.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.

    Sequence variations

    Mutation; HGNC; 11876; TMPRSS2; Simple; p.Gly8Val (c.23G>T) (c.-57+99G>T); dbSNP=rs75603675; Zygosity=Homozygous (PubMed=34339474).

    Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25275298).

    HLA typing Source: PubMed=26589293

    Class I

    HLA-A A*01:01,30:02

    HLA-B B*08:01,08:01

    HLA-C C*05:01,07:01

    Genome ancestry Source: PubMed=30894373

     

    Origin % genome

    African 0.92

    Native American 0

    East Asian, North 2.32

    East Asian, South 0.33

    South Asian 0

    European, North 46.86

    European, South 49.56

    Disease Tongue squamous cell carcinoma (NCIt: C4648)

    Squamous cell carcinoma of the oral tongue (ORDO: Orphanet_457252)

    Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)

    Sex of cell Male

    Age at sampling 69Y

    Category Cancer cell line

    STR profile Source(s): Cosmic-CLP=753541; DSMZ=ACC-447; PubMed=25275298; PubMed=36912284; Technion Genomics Center

     

    Markers:

    Amelogenin X,Y

    CSF1PO 11,12

    D1S1656 16,16.3

    D2S441 14

    D2S1338 20,25

    D3S1358 17

    D5S818 11,12

    D7S820 8,10

    D8S1179 13

    D10S1248 13,16

    D12S391 15,18

    D13S317 8,13

    D16S539 11

    D18S51 14

    D19S433 14,15.2 (Technion Genomics Center)

    14,16 (DSMZ=ACC-447)

    D21S11 29,30

    D22S1045 16

    DYS391 11

    FGA 21,22

    Penta D 12,13

    Penta E 7,15

    TH01 9,9.3

    TPOX 8

    vWA 17

     

    Run an STR similarity search on this cell line

    Publications

    PubMed=2440566

    Gioanni J., Samson M., Zanghellini E., Mazeau C., Ettore F., Demard F., Chauvel P., Duplay H., Schneider M., Laurent J.-C., Lalanne C.-M.

    Characterization of a new surface epitope specific for human epithelial cells defined by a monoclonal antibody and application to tumor diagnosis.

    Cancer Res. 47:4417-4424(1987)

     

    PubMed=3181269; DOI=10.1016/0277-5379(88)90335-5

    Gioanni J., Fischel J.-L., Lambert J.-C., Demard F., Mazeau C., Zanghellini E., Ettore F., Formento P., Chauvel P., Lalanne C.-M., Courdi A.

    Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment.

    Eur. J. Cancer Clin. Oncol. 24:1445-1455(1988)

     

    PubMed=2145926; DOI=10.1016/0277-5379(90)90186-W

    Olivier S., Formento P., Fischel J.-L., Etienne-Grimaldi M.-C., Milano G.

    Epidermal growth factor receptor expression and suramin cytotoxicity in vitro.

    Eur. J. Cancer 26:867-871(1990)

     

    PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113

    Bignell G.R., Greenman C.D., Davies H.R., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

    Signatures of mutation and selection in the cancer genome.

    Nature 463:893-898(2010)

     

    PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662

    Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.

    A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

    Cancer Res. 70:2158-2164(2010)

     

    PubMed=24710094; DOI=10.3390/genes1030388; PMCID=PMC3966227

    Bauer V.L., Hieber L., Schaeffner Q., Weber J., Braselmann H., Huber R., Walch A., Zitzelsberger H.

    Establishment and molecular cytogenetic characterization of a cell culture model of head and neck squamous cell carcinoma (HNSCC).

    Genes (Basel) 1:388-412(2010)

     

    PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027

    Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

    The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

    Nature 483:603-607(2012)

     

    PubMed=25275298; DOI=10.18632/oncotarget.2417; PMCID=PMC4253406

    Martin D., Abba M.C., Molinolo A.A., Vitale-Cross L., Wang Z.-Y., Zaida M., Delic N.C., Samuels Y., Lyons J.G., Gutkind J.S.

    The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.

    Oncotarget 5:8906-8923(2014)

     

    PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878

    Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P., Loewer M., Sahin U., Castle J.C.

    TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

    Genome Med. 7:118.1-118.7(2015)

     

    PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469

    Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Miro T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

    A landscape of pharmacogenomic interactions in cancer.

    Cell 166:740-754(2016)

     

    PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675

    Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

    An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

    Cancer Res. 79:1263-1273(2019)

     

    PubMed=30971826; DOI=10.1038/s41586-019-1103-9

    Behan F.M., Iorio F., Picco G., Goncalves E., Beaver C.M., Migliardi G., Santos R., Rao Y., Sassi F., Pinnelli M., Ansari R., Harper S., Jackson D.A., McRae R., Pooley R., Wilkinson P., van der Meer D.J., Dow D., Buser-Doepner C.A., Bertotti A., Trusolino L., Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.

    Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.

    Nature 568:511-516(2019)

     

    PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103

    Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. 3rd, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.

    Next-generation characterization of the Cancer Cell Line Encyclopedia.

    Nature 569:503-508(2019)

     

    PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254

    Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. 3rd, Kalocsay M., Jane-Valbuena J., Gelfand E.T., Schweppe D.K., Jedrychowski M.P., Golji J., Porter D.A., Rejtar T., Wang Y.K., Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A., Sellers W.R., Gygi S.P.

    Quantitative proteomics of the Cancer Cell Line Encyclopedia.

    Cell 180:387-402.e16(2020)

     

    PubMed=34339474; DOI=10.1371/journal.pone.0255622; PMCID=PMC8328321

    Pommerenke C., Rand U., Uphoff C.C., Nagel S., Zaborski M., Hauer V., Kaufmann M., Meyer C., Denkmann S.A., Riese P., Eschke K., Kim Y., Safranko Z.M., Kurolt I.-C., Markotic A., Cicin-Sain L., Steenpass L.

    Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies.

    PLoS ONE 16:E0255622-E0255622(2021)

     

    PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775

    Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

    Pan-cancer proteomic map of 949 human cell lines.

    Cancer Cell 40:835-849.e8(2022)

     

    PubMed=36912284; DOI=10.1002/ijc.34506

    Nguyen H.T., Tang W.-L., Webster A.L.H., Whiteaker J.R., Chandler C.M., Errazquin Ciudad R., Roohollahi K., Fritzke M., Hoskins E.E., Jonlin E.C., Wakefield L., Sullivan L.B., Chen E.Y., Dorsman J.C., Brakenhoff R.H., Paulovich A.G., Grompe M., Garcia-Escudero R., Wells S.I., Smogorzewska A., Monnat R.J. Jr.

    Fanconi anemia-isogenic head and neck cancer cell line pairs: a basic and translational science resource.

    Int. J. Cancer 153:183-196(2023)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    相关实验
    • 小鼠白细胞介素33(IL-33)酶联免疫分析

      小鼠白细胞介素33(IL-33) 酶联免疫 分析 试剂 盒使用说明书 本试剂仅供研究使用          目的:本试剂盒用于测定小鼠血清,血浆及相关液体样本中白细胞介素33(IL-33)的含量。 实验原理 :    本试剂盒应用双抗体夹心法测定 标本 中 小鼠白细胞介素33 ( IL-33 ) 水平。用纯化的 小鼠白细胞介素33 ( IL-33 ) 抗体包被微孔板,制成固相抗体,往包被单抗的微孔中依次加入 白细胞介素33 ( IL-33

    • 细胞介素IL-33

      细胞介素 IL-33   IL-33主要产生细胞:黏膜等多种组织细胞   IL-33氨基酸数目:270/266   IL-33分子质量(kDa):30/29.9   IL-33受体:IL-1受体;ST2   IL-33主要生物学活性:激活NFκB和MAPK途径,促进Th2细胞表达IL-4、1D5和IL-l3

    • 人白细胞介素33(IL-33)酶联免疫分析(ELISA)

      人 白细胞介素33(IL-33) 酶联免疫 分析( ELISA ) 试剂 盒使用说明书 本试剂仅供研究使用          目的:本试剂盒用于测定人血清,血浆及相关液体样本中白细胞介素33(IL-33) 的 含量。 实验原理 : 本试剂盒应用双抗体夹心法测定 标本 中 人白细胞介素33(IL-33) 水平。用纯化的 白细胞介素33(IL-33) 抗体包被微孔板,制成固相抗体,往包被单抗的微孔中依次加入 白细胞介素33(IL-33

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1980
    上海酶研生物科技有限公司
    2025年07月12日询价
    ¥1800
    博辉生物科技(广州)有限公司
    2025年10月28日询价
    ¥4500
    上海格宁生物科技有限公司
    2025年12月17日询价
    ¥680
    上海联迈生物工程有限公司
    2026年01月15日询价
    ¥2200
    上海钰博生物科技有限公司
    2025年07月12日询价
    文献支持
    CAL33细胞
    ¥1980